We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+12.43%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$6.03B
AUM Growth
+$589M
Cap. Flow
+$81.4M
Cap. Flow %
1.35%
Top 10 Hldgs %
18.86%
Holding
1,529
New
146
Increased
642
Reduced
570
Closed
93

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Financials 10.31%
3 Industrials 8.91%
4 Healthcare 8.6%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSY icon
451
Invesco Ultra Short Duration ETF
GSY
$3.86B
$2.48M 0.04%
49,741
+1,112
+2% +$55.5K
TRMB icon
452
Trimble
TRMB
$13.3B
$2.47M 0.04%
38,451
+556
+1% +$31.7K
TLT icon
453
iShares 20+ Year Treasury Bond ETF
TLT
$41.9B
$2.45M 0.04%
25,945
+3,113
+14% +$294K
EWM icon
454
iShares MSCI Malaysia ETF
EWM
$309M
$2.44M 0.04%
112,189
+7,451
+7% +$160K
KMB icon
455
Kimberly-Clark
KMB
$36.4B
$2.43M 0.04%
18,823
+1,219
+7% +$150K
EMN icon
456
Eastman Chemical
EMN
$7.97B
$2.42M 0.04%
24,129
-3,100
-11% -$273K
FDL icon
457
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.74B
$2.39M 0.04%
62,171
+1,468
+2% +$53.7K
RVT icon
458
Royce Value Trust
RVT
$2.21B
$2.39M 0.04%
157,553
+3,004
+2% +$43.3K
ANGL icon
459
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.08B
$2.39M 0.04%
82,304
+7,360
+10% +$212K
AME icon
460
Ametek
AME
$55.7B
$2.38M 0.04%
13,038
-200
-2% -$34.4K
HUN icon
461
Huntsman Corp
HUN
$1.73B
$2.38M 0.04%
91,488
+277
+0.3% +$6.87K
BMEZ icon
462
BlackRock Health Sciences Trust II
BMEZ
$967M
$2.38M 0.04%
145,268
+68,569
+89% +$1.08M
RQI icon
463
Cohen & Steers Quality Income Realty Fund
RQI
$1.7B
$2.38M 0.04%
196,934
+5,060
+3% +$60.1K
BSTZ icon
464
BlackRock Science and Technology Term Trust
BSTZ
$1.94B
$2.36M 0.04%
121,898
+20,781
+21% +$373K
SCCO icon
465
Southern Copper
SCCO
$145B
$2.36M 0.04%
23,920
+14,616
+157% +$1.17M
BOTZ icon
466
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.29B
$2.36M 0.04%
74,112
+29,236
+65% +$880K
TRV icon
467
Travelers Companies
TRV
$78.8B
$2.35M 0.04%
10,201
-4,922
-33% -$1.05M
NBIX icon
468
Neurocrine Biosciences
NBIX
$16.7B
$2.34M 0.04%
16,955
-214
-1% -$29.2K
DOV icon
469
Dover
DOV
$27.6B
$2.33M 0.04%
13,175
+4,760
+57% +$767K
SNOW icon
470
Snowflake
SNOW
$104B
$2.33M 0.04%
14,409
+7,974
+124% +$1.55M
AES icon
471
AES
AES
$10.5B
$2.32M 0.04%
129,607
+8,679
+7% +$145K
CRH icon
472
CRH
CRH
$63.9B
$2.32M 0.04%
26,838
+233
+0.9% +$17.8K
TMHC
473
DELISTED
Taylor Morrison
TMHC
$2.31M 0.04%
37,213
+8,068
+28% +$444K
FTV icon
474
Fortive
FTV
$17.9B
$2.31M 0.04%
35,668
-99
-0.3% -$6.01K
HUM icon
475
Humana
HUM
$44B
$2.31M 0.04%
6,655
+2,844
+75% +$1.08M

Similar funds

Oppenheimer & Co's Q1 2024 Portfolio in Review

As of Q1 2024, Oppenheimer & Co held 1,529 positions worth $6.03B, up 11% from $5.44B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Oppenheimer & Co's Q1 2024 filing shows 146 new, 642 increased, 570 reduced and 93 closed positions. Its largest new stake was State Street SPDR Portfolio Long Term Treasury ETF: 116,262 shares worth $3.25M. The largest sale was NVIDIA, an estimated $8.83M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

  • Oppenheimer & Co's largest Q1 2024 buy was State Street SPDR Portfolio Long Term Treasury ETF: 116,262 shares worth $3.25M.
  • Oppenheimer & Co added most to State Street SPDR S&P 500 ETF Trust in Q1 2024, an estimated $7.26M increase.
  • Oppenheimer & Co's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $8.83M.
  • Oppenheimer & Co fully exited Pacer Developed Markets International Cash Cows 100 ETF in Q1 2024, selling an estimated $2.89M.
  • Oppenheimer & Co's ten largest holdings make up 19% of its $6.03B portfolio in Q1 2024.
  • Oppenheimer & Co opened 146 new positions and closed 93 in Q1 2024.
  • Oppenheimer & Co's portfolio value rose 11% quarter-over-quarter to $6.03B.

Based on Oppenheimer & Co's 13F filing for Q1 2024, filed 7 May 2024.